Ownership Capital B.V. increased its position in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 35.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 488,629 shares of the company’s stock after acquiring an additional 126,908 shares during the quarter. Medidata Solutions comprises about 2.1% of Ownership Capital B.V.’s investment portfolio, making the stock its 20th largest position. Ownership Capital B.V. owned approximately 0.80% of Medidata Solutions worth $35,821,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of MDSO. World Asset Management Inc acquired a new position in Medidata Solutions in the second quarter valued at about $235,000. Zeke Capital Advisors LLC acquired a new position in Medidata Solutions in the second quarter valued at about $239,000. First Republic Investment Management Inc. acquired a new position in Medidata Solutions in the second quarter valued at about $242,000. Zions Bancorporation acquired a new position in Medidata Solutions in the second quarter valued at about $274,000. Finally, NJ State Employees Deferred Compensation Plan acquired a new position in Medidata Solutions in the third quarter valued at about $293,000.
Several equities analysts have weighed in on MDSO shares. Royal Bank of Canada raised Medidata Solutions from a “sector perform” rating to an “outperform” rating and set a $100.00 target price on the stock in a research note on Tuesday, July 17th. JPMorgan Chase & Co. lowered Medidata Solutions from an “overweight” rating to a “neutral” rating and set a $87.00 target price on the stock. in a research note on Tuesday, July 24th. ValuEngine lowered Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Tuesday, July 24th. Needham & Company LLC lowered Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, July 25th. Finally, Morgan Stanley set a $84.00 target price on Medidata Solutions and gave the company a “hold” rating in a research note on Wednesday, July 25th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $84.64.
Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Thursday, October 18th. The company reported $0.42 EPS for the quarter, topping the Zacks’ consensus estimate of $0.36 by $0.06. The company had revenue of $163.41 million for the quarter, compared to analyst estimates of $162.09 million. Medidata Solutions had a return on equity of 10.70% and a net margin of 8.43%. Medidata Solutions’s revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.33 earnings per share. Research analysts anticipate that Medidata Solutions Inc will post 0.85 earnings per share for the current fiscal year.
In other news, EVP Michael I. Otner sold 7,030 shares of the firm’s stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $69.40, for a total transaction of $487,882.00. Following the sale, the executive vice president now owns 62,548 shares of the company’s stock, valued at $4,340,831.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 4.70% of the company’s stock.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Featured Article: Bond
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.